Skip to main content
. Author manuscript; available in PMC: 2013 May 14.
Published in final edited form as: J Am Coll Cardiol. 2013 Jan 23;61(9):957–970. doi: 10.1016/j.jacc.2012.10.051

Figure 4. Association Between 9p21 and MI in Patients With Underlying CAD.

Figure 4

Odds ratios/copy of 9p21 risk allele for MI in subjects with CAD (allelic model), stratified according to CAD definition (clinical, angiographic stenosis ≥50% or ≥70%). Total n = 33,673; 17,791 CAD+/MI+, 15,882 CAD+/MI−. ADVANCE = Atherosclerotic Disease, Vascular Function, and Genetic Epidemiology; CAD/MI+ = cases with history of MI and underlying CAD; CAD/M− = control subjects without history of MI but with underlying CAD; LCAS = Lipoprotein and Coronary Atherosclerosis Study; PROCARDIS = Precocious Coronary Artery Disease; WTCCC = Wellcome Trust Case-Control Consortium; other abbreviations as in Figures 1, 2, and 3.